Lower extremity venous disorders encompass a spectrum of functional abnormalities of the venous system including chronic venous disease and chronic venous insuffi ciency (CVI). Clinical manifestations of CVI include leg pain, edema, skin changes such as hyperpigmentation (hemosiderosis), venous eczema, lipodermatosclerosis, and active or healed ulcers. In the United States, it is estimated that approximately 2.5 million people (between 10% and 35% of adults) have clinical manifestations of CVI.
INTRODUCTION
with VLU missed more days from work than did persons without VLU (14 vs 10 days; P < .0001), resulting in signifi cantly higher work loss costs. 3 Compression is the oldest and most widely used intervention for management of CVI. Correctly applied compression therapy is the cornerstone of treatment and has been shown to improve healing rates in patients with existing VLUs and reduce the likelihood of ulcer recurrence. 2 , 6-10 High-quality systematic reviews indicate that primary prevention with compression stockings improve CVI-related symptoms such as aching and itching when compared to no compression. 2 , 8 Compression has also been shown to improve healing of VLU when compared to no compression. 2 , 7-9 Despite multiple guidelines focusing on prevention and management of CVI and venous ulcers, application of compression in daily practice remains a challenge. While the various clinical guidelines concur that compression is a cornerstone of VLU treatment and prevention, they lack adequate detail concerning which form of compression is best for each patient. 2 , 7-9 , 11 , 12 Th is decision is especially complex, given the variety of infl uencing factors such as the goal of therapy (primary prevention of venous ulcers in patients with CVI, prevention of ulcer recurrence, or management of a current ulcer), patient tolerance, and variable resources needed to obtain and apply compression.
CONSTRUCTION OF THE ALGORITHM
In an eff ort to provide clinical guidance for providing individualized care to patients with CVI across the care continuum, the WOCN Society elected to develop an evidence-and consensus-based algorithm for compression in the patient with CVI. Society leaders assembled a Task Force of 3 expert clinicians in order to (1) identify evidence supporting the use of compression for prevention and management of VLU; (2) develop evidence-based statements needed to support the algorithm; (3) develop consensus-based statements needed to support decisions and pathways not supported by higher-level evidence; and (4) establish face validity of a fi rst draft of the VLU algorithm. Subsequently, a group of 20 key opinion leaders was convened to review the draft algorithm and evidence-based supporting statements and reach consensus on statements lacking adequate supporting evidence. Finally, an independent group of clinicians with expertise in CVI and venous ulcer care was asked to review the algorithm, establish its content validity, and suggest changes. Th is article summarizes each of these steps in the development of this landmark algorithm.
Scoping Literature Review
Th ree certifi ed WOC nurses (C.R., S.Y., and L.M.) with clinical expertise in chronic wounds of the lower extremity were appointed by WOCN Society leadership to act as a Task Force for generation and validation of the consensus and evidence-based algorithm for use of compression in the prevention and management of CVI and VLU. Task Force members began by identifying aims and search terms required for a scoping literature review. While the criteria that defi ne a scoping literature search continue to evolve, it can be broadly defi ned as a synthesis of the literature that maps key concepts, types of evidence, and gaps in research by systematically searching, retrieving, and synthesizing current best evidence. 13 , 14 To maximize effi ciency during this process, the Task Force appointed a facilitator (M.G.) with experience in this type of literature review and algorithm construction.
Th e scoping literature review was completed using the basic steps recommended by Colquhoun and colleagues. 13 Th is review was guided by the following aim: to identify evidence concerning the use of compression for prevention and management of CVI and VLU. Th e review was divided into 2 phases. In the fi rst phase, we searched the literature from 2005 to 2015 in order to identify evidence-based clinical practice guidelines for prevention and management of VLU and CVI. Th e search terms for this search were "venous ulcers," "venous leg ulcers," "chronic venous insuffi ciency," "compression," and "clinical practice guideline" along with the MESH terms "varicose ulcers," "venous insuffi ciency," "compression bandages," "compression stockings," "intermittent pneumatic compression devices," and "practice guidelines." We searched the MEDLINE and CINAHL electronic databases, Cochrane Library of Systematic Reviews, and United States Agency for Health Research and Quality National Guideline Clearinghouse. We limited the search to guidelines published in English and supported by an explicitly defi ned methodology for systematic review and generation of recommendations for clinical practice. Th is search identifi ed 8 clinical practice guidelines that met inclusion criteria; all were used in construction of the algorithm ( Table 1 ) . A second literature search was then conducted of the MED-LINE and CINAHL electronic databases from 2010 through 2015. Th is review more closely used techniques identifi ed for systematic literature reviews. 17 Th e aim of this phase of the scoping literature review was to identify the most recent studies focusing on the use of compression for prevention and management of CVI and VLU that may not have been included in the various Clinical Practice Guidelines identifi ed during the fi rst phase of our search. Key terms used for this search were "venous ulcers," "venous leg ulcers," "chronic venous insufficiency," "compression," and "clinical practice guideline" along with the MESH terms "varicose ulcers," "venous insuffi ciency," "compression bandages," "compression stockings," and "intermittent pneumatic compression devices." We limited the review to randomized controlled trials, systematic reviews with meta-analysis, and nonrandomized comparison cohort studies that examined the effi cacy of various forms of compression on prevention and management of VLU, primary prevention of VLU in persons with CVI, studies comparing the various forms of compression, and studies evaluating adherence to compression (an essential component of eff ectiveness). We excluded studies comparing compression products not available in the United States, studies performed in healthy volunteers, studies measuring outcomes other than VLU healing in persons with CVI, and studies measuring intermediate outcomes such as the magnitude of compression created when specific compression devices are applied to the lower extremities. Th e search was also limited to studies published in the English language. Th is review yielded 151 titles. Following elimination of foreign language articles, duplicate publications, and articles not reporting original data, the search was limited to 50 papers. Each of the 3 task force members completed title and abstract search of the remaining 50 titles for relevancy. Based on this review, 17 articles were retrieved and read in full by each task force member to determine if the study met inclusion criteria. Methodological quality was judged for each study by all 3 Task Force members; the risk of bias varied from low to high and most studies were found to have moderate to higher risk of bias. Nevertheless, no study was eliminated based on methodological weaknesses alone. Disagreements concerning study inclusion and methodological quality were resolved by discussion moderated by the Task Force facilitator. Eleven studies were selected that also provided a basis for evidence-based decision points and pathways within the algorithm ( Table 2 ) .
Th e Task Force also identifi ed and retrieved 9 key references used as a background for the algorithm. 8 , 29-36 Th ese references were used to provide supplemental materials for the algorithm.
Generation of Consensus-and Evidence-Based Statements and Development of the First Draft
Results from this scoping review were used to generate clinical decision points and various pathways for the algorithm. Th e strength of evidence from these statements was ranked using a 3-point ordinal scale adapted from the Level of Evidence Rating found in the WOCN Clinical Practice Guideline for Management of Wounds in Patients with Lower-Extremity Venous Disease 37 and the Strength of Recommendations Taxonomy (SORT) from the American Academy of Family Physicians ( Table 3 ) . Twenty-seven evidence-based statements were generated from the fi ndings of the scoping literature review ( Table 4 ) .
Following the scoping literature review and evidence-based statement development, the Task Force constructed a fi rst draft algorithm via a series of Web-based conference calls and face-to-face meetings. Members of the Task Force evaluated the face validity of this fi rst draft at multiple points during its development by identifying representative patient scenarios at their facilities and creating hypothetical scenarios and following each patient through the algorithm to ensure that the processes followed (e.g., assessments, considerations, reassessments), decision points, interim, and end results (e.g., recommendations for use of compression therapy) were comprehensive, feasible, and appropriate. Based on extensive discussion, the Task Force decided that the algorithm would focus on selection and application of compression therapy for the primary prevention, treatment, and prevention of recurrence of VLU associated with CVI.
As we generated this fi rst draft of the algorithm, Task Force members soon realized that multiple decision points and supplemental recommendations lacked adequate supporting evidence. As a result, the Task Force generated 38 statements from the draft algorithm that lacked suffi cient evidence to be deemed evidence-based (ie, Level of Evidence C). Rather than rely on agreement from the 3-member core group, the Task Force sought formal input from a representative group clinical experts who provide care for these patients. A Consensus Panel was brought together that represented the variety of clinicians (nurses, physicians, physical therapists) who care for persons with VLU and CVI, and the varied settings that compression and associated management of VLU and CVI occur (acute, ambulatory, long-term, and home health care settings) ( Table 5 ). Geographic diversity also infl uenced the choice of panel members. Invitations were extended to executive leaders of relevant professional organizations, authors of relevant clinical practice guidelines, and basic and applied scientists conducting research in this area of practice. Twenty persons were empaneled; 12 (60%) were advanced practice nurses, 2 (10%) were specialty practice RNs, 2 (10%) were physical therapists, 2 (10%) were researchers, 1 was a researcher with training as an engineer, and 1 was a surgeon. Eighty percent (n = 16) had national certifi cation in wound care.
Th e 2-day conference began with a summary of preconference activities and a brief state-of-the-science presentation on current practice in the area of compression for CVI and VLUs. Th is presentation was followed by introduction of the initial draft of the algorithm and discussion of the evidence-based statements previously generated; several statements were clarifi ed based on panel member input.
Nevertheless, the main task of the Consensus Panel was to reach formal consensus on statements guiding decision points and pathways of the algorithm that were not supported by level A or B evidence. Th e consensus process was facilitated by a clinician (M.G.) who does not routinely care for persons with CVI and VLU but has general knowledge of chronic wound 18 A total of 40 patients (median age 78 y) with C4-C6 CVI managed in a single ambulatory care center in Zurich, Switzerland Randomized controlled trial: subjects allocated to 40 mmHg or 2 superimposed 20 mmHg stockings with or without donning devices, neither subjects nor care providers were blinded to group allocation, data collection period not specifi ed Donning devices signifi cantly improved elderly patients' ability to correctly apply compression stockings.
Ashby et al (2014) 19 A total of 457 subjects (mean age 69 y) with CVI and current VLU recruited from 34 ambulatory care centers in England and Ireland Randomized controlled trial: subjects allocated to compression using 2-layer hosiery or 4-layer bandage system, groups stratifi ed based on VLU size and duration using permuted blocks, neither subjects nor care providers were blinded to treatment group; evaluators of main study outcome measure blinded to group allocation, data collection period 12 mo
No signifi cant differences found in median time to healing when 2-layer compression hosiery was compared to 4-layer bandage system.
Subjects allocated to 2-layer hosiery were more likely to change the type of compression style than did those managed by 4-layer compression bandage.
Dolibog et al (2013)

20
A total of 147 subjects aged 40-82 y with CVI and current VLU allocated to 5 types of compression, subjects recruited from multiple ambulatory care clinics in Poland but all were managed in a single site Randomized controlled trial: subjects allocated to 1 of 5 types of compression:
intermittent pneumatic compression, 30-40 mmHg compression stocking, multilayer short-stretch bandage, 2-layer short-stretch bandage, and rigid paste bandage/boot, patients and care providers were not blinded to treatment group; neither subjects nor care providers were blinded to treatment group, data collection period 2 wk
The rate of patients who experienced wound VLU healing or reductions in ulcer size after 8 wk was comparable in patients managed by intermittent pneumatic compression, compression stockings, and multilayer short-stretch bandages; it was signifi cantly lower in patients managed by 2-layer bandage and rigid paste bandage/boot.
Kapp et al (2013)
21
A total of 93 community-dwelling persons from Australia with VLU healed within 1 wk of study participation, mean age 73 y Randomized controlled trial: subjects allocated to compression using 23-32 mmHg (moderate) knee high compression stocking vs 24-36 mmHg (high) knee high compression stocking, the study was described as double blind, data collection period 6.5 mo
The risk of VLU recurrence was 3 times greater for subjects managed with moderate vs high compression stockings.
Mauck et al (2012) 10 Data extracted from 36 studies conducted beginning of 1990 to end of 2013; pooled sample size 4298 subjects Meta-analysis used to compare rates of VLU healing and time to healing in patients managed by compression stockings vs bandage systems, compression stockings vs short-stretch bandages, short-stretch bandages vs long-stretch bandages, data collection period among studies varied from 2 wk to 30 mo
No differences in VLU healing were found when all compression bandage systems were compared to compression stockings.
Results of a single study suggest that VLU recurrence rates are lower in patients managed by stockings vs bandage systems.
VLU healing rates were not different when 4-layer bandage systems were compared to systems with < 4 layers.
No differences in healing rates or time to healing were found when compression applied by short-stretch vas compared to compression via long-stretch bandage systems. Healing outcomes were better when patients received any form of compression vs no compression. Multicomponent bandage systems were more likely to heal VLU within 6 mo than single-component compression systems. Four-layer bandage systems were associated with faster healing than were short-stretch bandage systems.
Finlayson et al (2012) 22 A total of 103 patients with VLU and CVI (mean age 68 y) recruited from multiple local hospitals and 2 community nursing services, all study procedures performed in a single ambulatory care facility in Australia Randomized controlled trial: subjects allocated to compression using 4-layer compression bandage or Class III compression stockings (delivering 25-35 mmHg compression), neither subjects nor care providers were blinded to treatment group; evaluators of main study outcome measure blinded to group allocation, data collection period 6 mo
No differences found in healing rates at 24 wk, time to healing was signifi cantly less for patients managed with 4-layer bandage.
Lazareth et al (2012) 23 A total of 187 patients (mean age 72 y) with VLU and CVI recruited from outpatient care centers in 3 European countries, France, Germany, and the United Kingdom Randomized controlled trial: Subjects randomly allocated to compression using a 2-layer vs 4-layer bandaging system, no blinding procedures were described, data collection period 3 mo
The healing rates for the 2-layer bandaging system were not signifi cantly different from rates achieved by the 4-layer system.
(continues) 
Individual Studies Included in Generation of Statement for Algorithm Development ( Continued
)
Study
Subjects and Setting
Design
Outcomes of Interest to Construction of Algorithm
Weller et al (2012) 24 A total of 45 patients with VLU and CVI (mean age 75 y) recruited from multiple hospital-based outpatient centers in Victoria and Queensland, Australia Randomized controlled trials: subjects allocated to compression with 3-layer tubular bandaging system or compression with short-stretch bandage system, no blinding procedures performed, data collection period 3 mo
The healing rate for patients managed by the 3-layer bandage system was higher than the healing rate for patients managed by the shortstretch bandage system.
Wong et al (2012) 25 A total of 331 community-dwelling patients with VLU and CVI (mean age 72 y) recruited from multiple communities in Hong Kong Randomized controlled trial: subjects allocated to compression with short-stretch bandage system, long-stretch bandages, or topical care without compression, no blinding procedures were reported, data collection period 6 mo
Patients managed by short-stretch or long-stretch bandages had higher healing rates than those managed without compression.
Harrison et al (2011) 26 A total of 424 persons (mean age 65 y) receiving home care services for VLU and CVI in multiple regions of Canada Randomized controlled trial: subjects allocated to compression with 4-layer bandage system or short-stretch bandage system, neither subjects nor home health nurses were blinded to group allocation, data collection 12 mo
Healing rates did not differ between 4-layer vs short-stretch bandage systems.
Brizzio et al (2010) 27 A total of 60 community-dwelling patients (mean age female subjects 62 years; median age male subjects 63 y) with CVI and VLU recruited from outpatient care centers in Buenos Aires Randomized controlled trial: subjects allocated to compression with short-stretch bandage system or compression stocking placed over gauze dressing, no blinding procedures, data collection period 6 mo
No differences in healing rates were noted in patients allocated to short-stretch bandage system vs those allocated to the compression stocking.
Szewczyk et al (2010) 28 A total of 49 community-dwelling patients managed in clinical ward of hospital in Bydgoszcz, Poland Randomized controlled trial: subjects allocated to compression with 30-40 mmHg compression stocking, 2-layer short-stretch bandage system or 4-layer bandage system, no blinding procedures were described, data collection period 3 mo
No differences in reductions in ulcer size found when 2-layer shortstretch bandages, compared to 4-layer bandage system or 30-40 mmHg compression stocking.
Abbreviations: CVI, chronic venous insuffi ciency; VLU, venous leg ulcer.
care and prior experience in this type of facilitation. Consensus on each statement was obtained based on the principles outlined by Murphy and colleagues, 39 using 80% agreement as the criterion for obtaining consensus. Statements were initially read to panelists and an initial vote was taken; clinicians were asked whether they agreed or disagreed with the recommendation for care or management expressed by the statement. If consensus was not achieved on the fi rst vote, facilitated discussion occurred and the statement was edited based on panel member input. Th is process was repeated for up to 3 rounds of discussion until consensus was reached by formal vote. If consensus could not be reached after 3 rounds of discussion, or the statement deemed irrelevant to algorithm development, the statement was classifi ed as "unable to reach consensus" and removed from further discussion. An interactive software program and wireless response system (Audio Visual One, Ltd, Bedford Park, Illinois) was used for all consensus votes. An electronic system was selected because it allowed feedback concerning progress toward consensus within a matter of seconds, and because it enabled anonymous voting by participants, thus reducing the risk of bias associated with public voting. As a result of this conference, consensus was reached on all statements used to support decision points and supplemental materials within the algorithm; no statements were eliminated ( Table 6 ) .
Following the conference, the Task Force revised the algorithm to incorporate the revised consensus-based and evidence-based statements into a second draft of the algorithm. Th is draft also incorporated supplemental materials deemed necessary since the algorithm is intended for use by a variety of clinicians with variable knowledge of CVI and VLU prevention and management.
Content Validation and Generation of the Final Draft
Th e process used for content validation was based on the technique described by Waltz and Bausell 40 and subsequently modifi ed by Lynn 41 and Grant and Davis. 42 A data collection form was developed to evaluate content validity of the algorithm and 21 experts in the fi eld of CVI and VLU prevention and management, including use of compression, were identifi ed ( Table 7 ) . Th e form contained demographic data regarding professional and educational background of respondents, and the number of years of experience in wound care and/or research. Nine sections representing various pathways in the algorithm were developed. Content experts were asked to rank individual items on a scale of 1 to 4, where 1 indicated not relevant/appropriate; 2 indicated unable to assess relevance without revision, 3 indicated relevant but needs minor alteration, and 4 indicated very relevant and appropriate. Th is second group of clinical experts was also given the opportunity to provide qualitative feedback (written comments and suggestions) on the comprehensiveness of the algorithm, omissions of essential content, and suggest changes to improve clarity, parsimony, and relevance.
Data were analyzed using Statistical Analysis Software version 9.4 (SAS Institute Inc., Cary, North Carolina). Data were coded and entered by a single data coordinator, analyzed by the biostatistician, and reviewed by the authors of this article. Content validity ratings were entered for 9 individual sections of the algorithm and the overall algorithm, and the content validity index was calculated for each section and the overall algorithm. 43 Th e content validity index for the overall algorithm was 0.86, which is well above the suggested cut-point of 0.78 suggested by Polit and Beck 44 for establishing content validity based on feedback from 3 or more reviewers. Th e content www.jwocnonline.com validity indices for the 9 pathways of the algorithm varied from 0.86 to 1.0 ( Table 8 ) . Th ese fi ndings indicate that the majority of expert panelists found that the overall algorithm and each of its 9 pathways were "very relevant and appropriate" or "relevant and needed only minor alteration."
Content validators were also asked to provide qualitative feedback for the overall algorithm and each of its 9 pathways. Qualitative feedback focused on language used in the algorithm, options for therapies to complement the eff ectiveness of compression such as pharmacological agents, parameters for Ankle Brachial Index (ABI), also known as Ankle Brachial Pressure Index (ABPI) testing indicating clinically relevant arterial disease, a desire for more specifi c follow-up times, and suggestions for various additions to assessment of patients with CVI. Th e Task Force made multiple changes to the algorithm based on this qualitative feedback.
ALGORITHM FOR COMPRESSION CVI WITH AND WITHOUT VLU
Th e target audience for the algorithm includes nurses, specialty and advanced practice providers (wound care nurses, WOC nurses, vascular nurses, nurse practitioners, clinical nurse specialists, physician's assistants, etc), physicians (hospitalists, primary care physicians, vascular and other surgeons), physical therapists, and occupational therapists. Th e algorithm was designed for adult patients in acute care facilities (critical care, medical-surgical, orthopedic, rehabilitation units, and the emergency department), long-term acute care facilities, outpatient clinics, long-term care/skilled nursing homes, and home care settings.
Both the Task Force and Consensus Panel members engaged in extensive discussion concerning the importance of a classification system for CVI to enable standardization of assessment, management, and treatment of VLU, including compression. Chronic venous insuffi ciency can be described in terms of the well-established Clinical, Etiology, Anatomic, Pathophysiology (CEAP) classifi cation system developed by an ad hoc committee of the American Venous Forum in 1994 and revised by an international consensus committee in 2004. 45 , 46 Th is classifi cation system has 7 categories (0-6) defi ned by the presence or absence of signs or symptoms. Strategies for the prevention of the progression of CVI from "pre-ulcer stages" CEAP C1 to C5 should be implemented to avoid focusing on the treatment of the ulcer only.
Users enter the algorithm when a patient presents with complaints related to their lower extremities (see the Figure ) . Th e clinician begins with review of the medical record, followed by completion of a health history and focused physical exam. Once assessment is complete, the clinician should determine the need for appropriate diagnostic studies, which may include ABI/ ABPI testing. 37 , 47 If access to results is delayed, the clinician may continue the diff erential diagnosis and refer to tools identifi ed in the algorithm. If patient is found to have a disease or wound of other etiology (eg, lymphedema, lipedema, arterial, or neuropathic), the user should follow facility protocol or practice guideline for those conditions. 37 Periodic patient reassessment of the lower extremities should occur on a regular basis.
If the patient's lower extremity complaints and diagnostic tests are determined to be unrelated to venous disease (CEAP 0), the clinician is guided to provide education promoting leg health. Th ese patients should be reassessed at least annually to identify any new or worsening problems with the legs; reassessment may be integrated with a general physical examination.
When assessment reveals CVI, the clinician is directed to determine the clinical CEAP level. 45 must fi rst determine the need for compression. If compression is not needed, the clinician is guided to provide education promoting leg health from an expanded list. When compression is needed, the clinician must take into consideration individual patient characteristics, such as dexterity, mobility, preference, pain level cost, caregiver resources, and size and shape of the leg, and is assisted in their decision-making process by the provision of 4 tables. Patients with a prior history of deep vein thrombosis (DVT) should use a compression system that delivers 30 to 40 mmHg. 2 In contrast, patients with no history of DVT may use a compression system delivering 20 to 30 mmHg. Standardized methods based on the manufacturer's recommendations should be used when measuring for compression stockings or devices. Patient education regarding compression stockings/devices should be provided in addition to information about leg health. Periodic reassessment of the lower extremities should occur on a regular basis and at least twice annually.
For patient classifi ed as clinical CEAP 3-4, treatment is based on results of ABI (ABPI) measurement. If the ABI/ABPI is < 0.5 (indicating clinically relevant ischemia from arterial disease) or > 1.3 (indicating possible arterial disease with noncompressible vessels) compression should not be applied. 47 Instead, the clinician should educate patient and caregiver on leg health and consider referral for evaluation and management of signifi cant arterial disease and pharmacotherapy in selected cases. Periodic patient reassessment of the lower extremities should occur on a regular basis (at least every 6 months).
Patients with an ABI/ABPI of 0.5 to 0.8, indicating mixed venous and arterial disease, may be managed by modifi ed light compression/support up to 30 mmHg, depending on the individual's tolerance. 2 , 8 If the patient's ABI/ABPI is 0.8 to 1.3, a higher level of compression is indicated. Standardized methods based on the manufacturer's recommendations should be used when measuring for compression stockings or devices. Patient education regarding compression stockings/devices should be provided in addition to information about leg health and pharmacotherapy when indicated. A previous history of DVT also infl uences the desired level of compression.
2 When dermatitis or eczema is observed, treatment with topical steroids is indicated, long with referral to a dermatologist if treatment is ineff ective. 29 Th e algorithm also guides the clinician to consider referral to a specialist for further testing and intervention if indicated. Periodic patient reassessment is recommended at least every 6 months to identify any new problems with the legs and to evaluate status of ongoing compression therapy.
Clinical CEAP 5 is characterized by a patient who has experienced a VLU that has now healed. Compression continues to be a mainstay of treatment for all patients with clinical CEAP 5 CVI. As with clinical CEAP 3-4, ABI/ ABPI is used to determine the level of compression. If the person's ABI/ABPI is less than 0.5 or more than 1.3, further evaluation is required before compression is considered. 47 Th e clinician should educate the patient and the caregiver on leg health including pharmaceuticals if applicable. An ABI/ ABPI of 0.5 to 0.8 indicates mixed venous and arterial disease; these persons may require modifi ed light compression/ support up to 30 mmHg, based on patient tolerance. 2 , 8 For patients whose ABI (ABPI) is 0.8 to 1.3, higher compression is indicated. When selecting the type and level of compression, the same considerations must be given to individual patient characteristics as those described earlier. Standardized methods based on the manufacturer's recommendations should be used when measuring for compression stockings or devices. If dermatitis/eczema is present, treatment with topical steroids is indicated with referral to a dermatologist if treatment is ineff ective. Patient education regarding compression stockings/ devices should be provided in addition to information about leg health and pharmacotherapy when indicated. Th e clinician is guided to consider referral to the specialist for further testing 
Consensus Statements Used for Algorithm Construction
Statement
Level of Agreement
Assessment Statements
Essential components of a focused health history for chronic venous insuffi ciency include: 80%
• Triggers (eg, trauma, cellulitis, contact dermatitis, etc)
• Risk factors (eg, family history, previous deep vein thrombosis, fractures to leg, etc)
• Comorbid conditions (eg, obesity, thrombophilias, varicose veins, etc).
Essential components of a physical assessment for chronic venous insuffi ciency includes examination of both lower extremities noting condition of the skin, ankle range of motion and calf muscle strength, functional mobility, extent and location of edema, superfi cial vascular changes, presence of any wounds, and palpation of pulses.
100%
Arterial circulation should be evaluated using appropriate diagnostic studies such as Ankle Brachial Index (ABI), Ankle Brachial Pressure Index. 85%
Comprehensive management of CVI should be based on the CEAP (Clinical Etiology, Anatomy, Physiology) classifi cation system. 90%
If the patient's clinical CEAP score is C0, consider alternative etiologies for abnormal fi ndings. 80%
If the patient's clinical CEAP score is C0, educate patient and family about lifestyle factors that promote leg health including: 90%
• effects of smoking, advise smoking cessation
• follow healthy nutrition practices such as weight management
• avoid mechanical trauma to leg
• avoid crossing legs, prolonged sitting or standing
• exercise and participate in physical activity often
• avoid wearing high heels.
Decision points based on clinical CEAP level
If the patient's clinical CEAP score is C0-C6 80%
• Periodic reassessment is indicated.
• Patient and family/caregiver education is recommended.
If the patient's clinical CEAP score is CI-C4, determine type of compression based on patient dexterity, mobility, preference, pain/comfort, cost, caregiver resources, and size and shape of leg.
95%
If the patient's clinical CEAP score is C1-C4, use standardized methods based on the manufacturer's recommendations when measuring for compression stockings or devices.
If the patient's clinical CEAP score is C1-C2, use compression stockings or devices at a level of 20-30 mm Hg, knee or thigh high during waking hours to prevent venous ulcers.
90%
If the patient's clinical CEAP score is C1-C2, educate patient and family/caregiver about: 100%
• avoid prolonged sitting or standing
• extremity elevation
• prevention of trauma
• appropriate footwear (eg, avoid high heels)
• nutrition, weight management
• use of emollients to prevent dermatitis
• use of compression stockings/devices.
If the patient's clinical CEAP score is C1-C2, prophylactic interventional therapies to prevent VLU are not recommended in patients with asymptomatic C1-C2 disease.
95%
If the patient's clinical CEAP score is C1-C2, apply compression therapy, at a level of 20-30 mm Hg, knee or thigh high to prevent venous ulcers.
If the patient's clinical CEAP score is C3-C4, educate patient and family/caregiver about: 90%
• avoid mechanical trauma to leg 
Consensus Statements Used for Algorithm Construction ( Continued )
Statement
Level of Agreement
• use of compression stockings/devices
• use of pharmaceuticals (horse chestnut seed oil, pentoxifylline [Trental]), if applicable.
If the patient's clinical CEAP score is C3-C4, consider further testing such as venous duplex ultrasound and referral to a specialist for interventional therapies if indicated.
100%
If the patient's clinical CEAP score is C3-C6, consider the use of modifi ed light compression/support, up to 30 mm Hg, based on patient tolerance in patients with mixed venous and arterial disease (ABI = 0.5-0.8).
90%
If the patient's clinical CEAP score is C5, educate patient and family/caregiver about: 95%
• use of lifelong compression stockings/devices
• use of pharmaceuticals (horse chestnut seed oil, pentoxifylline), if applicable.
If the patient's clinical CEAP score is C5, consider donning/doffi ng devices, alternative compression devices, or continuation of wraps in patients/caregivers with functional limitations affecting stocking use. Consider referral to rehabilitation services to address functional limitations.
If the patient's clinical CEAP score is C5, avoid the use of paste bandage systems in nonambulatory and bedbound patients. 80%
If the patient's clinical CEAP score is C5, for patients with atypical leg size or shape, refer to a qualifi ed fi tter for measuring and selecting customized stockings, garments, and devices.
100%
If the patient's clinical CEAP score is C5, refer to a qualifi ed fi tter for measuring and selecting customized stockings, garments, and devices for patients with atypical leg size or shape.
80%
If the patient's clinical CEAP score is C5, consider further testing such as venous duplex ultrasound and referral to a specialist for interventional therapies if indicated.
95%
If the patient's clinical CEAP scores in C3-C6, consider reusable wraps, garments, or devices when selecting type of compression in patients with limited fi nancial resources.
90%
If the patient's clinical CEAP score is C6, sustained compression is not recommended if the ankle brachial index is less than 0.5 or if absolute ankle pressure is less than 60 mm Hg.
If the patient's clinical CEAP score is C6, apply topical dressing that will manage venous leg ulcer exudate. 85%
If the patient's clinical CEAP score is C6, apply emollients to intact skin underneath compression to prevent occurrence of dermatitis. 90%
If the patient's clinical CEAP score is C6, assess and monitor pain and circulatory status with use of compression. 100%
If the patient's clinical CEAP score is C6, educate patient and family about: 100%
• exercise and participate in physical activity often ( continues ) 
Consensus Statements Used for Algorithm Construction ( Continued )
Statement
Level of Agreement
• wound care and compression management
• use of pharmaceuticals (horse chestnut seed oil, pentoxifylline).
If the patient's clinical CEAP score is C6, consider the use of elastic bandages in nonambulatory and bedbound patients, who need therapeutic levels of compression.
80%
If the patient's clinical CEAP score is C6, modify compression and consider referral to a qualifi ed fi tter for measuring and selecting customized stockings, garments, and devices for patients with atypical leg size or shape.
100%
If the patient's clinical CEAP score is C6, consider lower levels of compression to enhance adherence in patients who cannot tolerate 30-40 mmHg of compression.
95%
If the patient's clinical CEAP score is C6, wrap from metatarsal head to tibial tubercle, including the heel when applying compression wraps. 100%
If the patient's clinical CEAP score is C6, consider further testing such as venous duplex ultrasound and referral to a specialist for interventional therapies if indicated.
90%
If the patient's clinical CEAP score is C6, consider principles of wound bed preparation prior to selection of topical therapy. 95%
If the patient's clinical CEAP score is C6 and the wound fails to improve or deteriorates, evaluate for barriers to healing. 90%
If the patient's clinical CEAP score is C4-C6, identify and treat dermatitis/eczema with topical steroids for 1-2 wk; refer to a dermatologist if treatment is ineffective.
and intervention if indicated. Periodic patient reassessment of the lower extremities should occur at least every 6 months. Individuals with a current VLU are classifi ed as clinical CEAP 6. Topical treatment of the ulcer is the primary consideration beginning with wound bed preparation. Th e 3 components of wound bed preparation are debridement of nonviable tissue, recognition and treatment of wound infection, and moisture balance management within the wound. Moisture balance management is critical with exudative wounds such as VLUs to promote healing and prevent periwound moisture-associated skin damage. Th ere are a variety of dressing categories that are absorbent (eg, hydrocolloids, alginates, gelling fi bers, foams, superabsorbents) which will wick the VLU exudate from the wound and periwound area. 48 However, managing periwound moisture-associated skin damage is a balancing act; avoiding both excessive dryness seen with venous stasis dermatitis, and excessive moisture in the wound and periwound skin can be challenging. In addition, a nonsensitizing emollient should be used under compression to prevent dermatitis. 29 Topical steroids may be used to treat dermatitis; referral to a dermatologist if treatment proves ineff ective within a period of 2 to 4 weeks.
Th e algorithm directs clinicians to obtain an ABI/ABPI because it assists the clinician in determining the level of compression. An ABI/ABPI < 0.5 indicates severe arterial disease and a contraindication for use of compression. 47 In this case, the clinician is guided to consider referral for evaluation and management of signifi cant arterial disease. Patients with an ABI/ABPI of 0.5 to 0.8 are diagnosed as having mixed venous and arterial disease. Th is individual may require modifi ed light compression/support up to 30 mmHg, based on tolerance. For patients whose ABI/ABPI is 0.8 to 1.3, higher compression is indicated.
2 , 8 When selecting the type and level of compression, the same considerations must be given to individual patient characteristics as those described earlier. Standardized methods based on the manufacturer's recommendations should be used when measuring for compression stockings or devices. Dermatitis or eczema should be treated as described previously. Patient education regarding compression stockings/ devices should be provided in addition to information about leg health and pharmaceuticals. If the wound fails to improve or deteriorates, barriers to healing should be evaluated. Th e clinician is guided to consider referral to the specialist for advanced adjuvant therapies. Periodic patient reassessment of the success of compression therapy should occur on a regular basis, at least every 6 months and more frequent reassessment may be indicated based on wound characteristics and response to treatment. If treatment is eff ective, current therapy should be continued until the wound heals. Once the wound heals, the clinical CEAP level changes to clinical CEAP 5 and the clinician is guided to clinical CEAP 5 section of the algorithm.
Supplemental Materials
Multiple supplemental materials were embedded into the algorithm in order to guide clinicians with variable expertise in CVI and VLU when using compression for prevention and management of VLU in persons with CVI. Because the ABI/ ABPI is critical to the diagnostic process, a quick-reference guide, including an interpretive table, 47 is provided. To further assist with diagnosis, appendices from the WOCN Society's Guideline for Management of Wounds with Lower Extremity Venous Disease have been included. 37 Th ese assist the user in discerning among edema, lymphedema, and lipedema, and distinguishing venous eczema from cellulitis. A reference regarding wounds of other etiologies has also been provided. 49 When clinical fi ndings indicate CVI, a reference 
DISCUSSION
An evidence-and consensus-based algorithm for Compression in CVI with or without VLU was developed and its content validity established. Algorithm construction followed a structured pathway and combined current best evidence to support pathways and decision points within the algorithm with consensus-based decision points when supportive evidence was lacking. Face validity was assessed at multiple points as the algorithm was constructed. In addition, the initial draft of the algorithm was subjected to scrutiny by a consensus panel of 20 clinicians and researchers with expertise in CVI and VLU, resulting in substantive and meaningful changes.
Following construction of a second draft, the algorithm was subjected to review by an independent panel of 21 expert clinicians. Th e overall content validity index for the algorithm was robust at 0.86 and the indices for the 9 pathways of the algorithm were equally strong varying from 0.86 to 1.0 ( Table 7 ) . Th e algorithm was designed for adult patients in acute care facilities, long-term acute care facilities, outpatient clinics, long-term care/skilled nursing homes, and home care settings. It was constructed to assist clinicians in these health care settings to determine need for and correctly apply compression for persons with CVI with or without VLU. However, the algorithm is not meant to provide comprehensive management of CVI with or without VLU. We acknowledge that adjunctive therapies, including pharmacotherapy, remain controversial. Nevertheless, their presence in the algorithm refl ects their presence in the daily practice of many clinicians managing patients with CVI with or without VLU rather than an endorsement of these medications, given the paucity of evidence. Th e algorithm provides evidence-or consensus-based guidance toward selection of product categories when choosing compression; it intentionally avoids recommendation of any specifi c products. Such choices are profoundly infl uenced by local factors such as clinician comfort with certain products, facility considerations such as contractual arrangements, and individual patient factors such as tolerance, aff ordability, and access to specifi c products.
CONCLUSION
A consensus-and evidence-based algorithm was constructed to aid clinicians select and apply compression for primary prevention, treatment, and prevention of recurrent VLU in patients with CVI. Nurses, physicians, physical therapist, and occupational therapists practicing in all health care settings are strongly encouraged to adapt this algorithm into their practice.
